ClinConnect ClinConnect Logo
Search / Trial NCT05991687

Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination

Launched by UNIVERSITY OF MICHIGAN · Aug 7, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Opioids Drug Disposal

ClinConnect Summary

This clinical trial is looking at the best ways to safely dispose of leftover prescription opioid pain medications after surgery. It compares two methods: sending the unused pills through the mail versus throwing them away at home. The goal is to find out which method helps ensure that these medications are disposed of properly, reducing the risk of misuse or accidental ingestion.

To be eligible for this trial, you should be between the ages of 65 and 74, and you need to be scheduled to have surgery where you will be prescribed opioid medications for pain relief afterward. Participants will be asked to follow up via email or phone to share their experiences with the disposal methods. It’s important to know that if you can't be contacted by email or phone, you won't be able to join the study. This trial is currently looking for volunteers, and your participation could help improve safety for others after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Anticipated to be prescribed and use an opioid medication to treat acute pain after elective outpatient surgery
  • Opioid-naive
  • Exclusion Criteria:
  • Inability to receive email and/or phone calls for follow up assessment

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Mark Bicket, MD, PhD

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported